10-Q

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

FORM 10-Q

x	Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended March 31, 2007
or
o	Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from                  to               

Commission file number 0-17171

URANIUM RESOURCES, INC.

(Exact Name of Issuer as Specified in Its Charter)

DELAWARE	75-2212772
(State of Incorporation)	(I.R.S. Employer Identification No.)

650 S. Edmonds Lane, Suite 108, Lewisville, Texas 75067

(Address of Principal Executive Offices)

(972) 219-3330

(Issuer’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x  Yes    o  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12-b2 of the Exchange Act.

(Check
one): Large accelerated filer  o Accelerated filer  x Non-accelerated filer  o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12-b2 of the Exchange Act).

o  Yes    x  No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Title of Each Class of Common Stock	Number of Shares Outstanding
Common Stock, $0.001 par value	52,718,212 as of May 7, 2007

URANIUM RESOURCES, INC.
2007 FIRST QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION
	Item 1.	Financial Statements
		Consolidated Balance Sheets- March 31, 2007 (unaudited) and December 31, 2006
		Consolidated Statements of Operations - three months ended March 31, 2007 and 2006 (Unaudited)
		Consolidated Statements of Cash Flows - three months ended March 31, 2007 and 2006 (Unaudited)
		Notes to Consolidated Financial Statements – March 31, 2007 (Unaudited)
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk
	Item 4.	Controls and Procedures
PART II — OTHER INFORMATION
	Item 1.	Legal Proceedings
	Item 1A.	Risk Factors
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds
	Item 3.	Defaults Upon Senior Securities
	Item 4.	Submission of Matters to a Vote of Security Holders
	Item 5.	Other Information
	Item 6.	Exhibits and Reports on Form 8-K
SIGNATURES
Index to Exhibits

2

URANIUM RESOURCES, INC.

CONSOLIDATED BALANCE SHEETS

ASSETS

	March 31,			December 31,
	2007			2006
	(Unaudited)
Current assets:
Cash and cash equivalents	$	16,560,467		$	20,176,771
Receivables, net	1,119,337			713,529
Uranium and materials/supplies inventory	2,085,010			1,603,585
Prepaid and other current assets	401,388			410,000
Total current assets	20,166,202			22,903,885
Property, plant and equipment, at cost:
Uranium properties	71,434,781			67,153,797
Other property, plant and equipment	573,018			465,613
Less-accumulated depreciation, depletion and impairment	(51,634,112		)	(49,423,848		)
Net property, plant and equipment	20,373,687			18,195,562
Other assets	2,256,497			2,369,434
Long-term investment:
Certificate of deposit, restricted	2,519,006			2,467,491
	$	45,315,392		$	45,936,372

The accompanying notes to financial statements are an integral part of these consolidated statements.

3

LIABILITIES AND SHAREHOLDERS’ EQUITY

	March 31,			December 31,
	2007			2006
	(Unaudited)
Current liabilities:
Accounts payable	$	2,021,701		$	1,994,184
Current portion of restoration reserve	1,327,026			1,520,192
Accrued interest and other accrued liabilities	1,005,811			816,877
Current portion of long-term debt	236,993			201,804
Total current liabilities	4,591,531			4,533,057
Other long-term liabilities and deferred credits	3,924,077			3,998,229
Long-term debt, less current portion	659,416			635,691
Commitments and contingencies (Notes 1, 2 and 3)
Shareholders’ equity:
Common stock, $.001 par value, shares authorized: 200,000,000; shares issued and outstanding (net of treasury shares): 2007—51,797,339; 2006—51,791,339	51,835			51,829
Paid-in capital	127,044,297			126,252,871
Accumulated deficit	(90,946,346		)	(89,525,887		)
Less: Treasury stock (38,125 shares), at cost	(9,418		)	(9,418		)
Total shareholders’ equity	36,140,368			36,769,395
	$	45,315,392		$	45,936,372

The accompanying notes to financial statements are an integral part of these consolidated statements.

4

URANIUM RESOURCES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended March 31,
	2007			2006
Revenues:
Uranium sales—	$	4,574,167		$	1,068,589
Total revenue	4,574,167			1,068,589
Costs and expenses:
Cost of uranium sales—
Royalties and commissions	438,976			79,435
Operating expenses	1,787,063			1,523,592
Accretion/amortization of restoration reserve	170,180			132,974
Depreciation and depletion	1,487,049			616,839
Gain on derivatives	—			(34,294,072		)
Total (gain on) cost of uranium sales	3,883,268			(31,941,232		)
Earnings from operations before corporate expenses	690,899			33,009,821
Corporate expenses—
General and administrative	2,212,092			1,056,752
Depreciation	21,162			5,971
Total corporate expenses	2,233,254			1,062,723
Earnings (loss) from operations	(1,542,355		)	31,947,098
Other income (expense):
Interest expense	(7,866		)	(2,739		)
Interest and other income, net	129,762			213,787
Net earnings (loss)	$	(1,420,459	)	$	32,158,146
Net earnings (loss) per common share:*
Basic	$	(0.03	)	$	0.79
Diluted	$	(0.03	)	$	0.73
Weighted average common shares and common equivalent shares per share data:*
Basic	51,795,006			40,954,437
Diluted	51,795,006			44,221,134

*Net earnings (loss) per share and weighted average common shares information reflects the effect of a reverse 1 for 4 stock split made effective April 11, 2006.

The accompanying notes to financial statements are an integral part of these consolidated statements.

5

URANIUM RESOURCES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended March 31,
	2007			2006
Net earnings (loss)	$	(1,420,459	)	$	32,158,146
Reconciliation of net earnings (loss) to cash provided by (used in) operations—
Gain on derivatives	—			(34,294,072		)
Accretion/amortization of restoration reserve	170,180			132,974
Depreciation and depletion	1,508,211			622,810
Decrease in restoration and reclamation accrual	(330,720		)	(247,817		)
Stock compensation expense	773,672			396,899
Other non-cash items, net	152,738			108,727
Effect of changes in operating working capital items—
Increase in receivables	(405,808		)	(372,937		)
(Increase) decrease in inventories	198,886			(31,791		)
Increase in prepaid and other current assets	(132,793		)	(84,025		)
Increase in payables, accrued liabilities and deferred credits	216,451			1,320,623
Net cash provided by (used in) operations	730,358			(290,463		)
Investing activities:
Increase in certificate of deposit, restricted	(51,515		)	(158,631		)
Additions to property, plant and equipment—
Kingsville Dome	(1,763,946		)	(3,289,633		)
Vasquez	(248,952		)	(923,407		)
Rosita	(1,093,373		)	(70,493		)
Rosita South	(539,537		)	—
Churchrock	(211,389		)	(171,686		)
Crownpoint	(29,871		)	(47,292		)
Other property	(353,424		)	(434,855		)
Other assets	(4,257		)	—
Net cash used in investing activities	(4,296,264		)	(5,095,997		)
Financing activities:
Payments on borrowings	(68,158		)	(782		)
Issuance of common stock, net	17,760			—
Net cash used in financing activities	(50,398		)	(782		)
Net decrease in cash and cash equivalents	(3,616,304		)	(5,387,242		)
Cash and cash equivalents, beginning of period	20,176,771			5,852,716
Cash and cash equivalents, end of period	$	16,560,467		$	465,474

The accompanying notes to financial statements are an integral part of these consolidated statements.

6

Uranium Resources, Inc.

Notes to Consolidated Financial Statements March 31, 2007 (Unaudited)

1.BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Item 310(b) of Regulation S-K.  Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.  The accompanying statements should be read in conjunction with the audited financial statements included in the Company’s 2006 Annual Report on Form 10-K/A.  In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.  Operating results for the three months ended March 31, 2007 are not necessarily indicative of the results that may be expected for the full calendar year ending December 31, 2007.

Reverse Stock Split

On March 29, 2006 the Company’s Board of Directors declared a 1 for 4 reverse stock split for stockholders of record on April 10, 2006, effective April 11, 2006.  The split was approved by stockholders at the 2005 Annual Meeting of Stockholders.  All common stock share amounts, earnings per share data and references to the common stock of the Company in this report are stated on a post-split basis.

2.DESCRIPTION OF BUSINESS

URI was organized in 1977 to mine uranium in the United States using the in situ recovery (“ISR”) mining process. This process is generally more cost effective and environmentally benign than conventional mining techniques. From 1988 through 1999 we produced about 6.1 million pounds of uranium from two South Texas properties, 3.5 million pounds from Kingsville Dome and 2.6 million pounds from Rosita.

In 1999 we shut-in our production because of depressed uranium prices, and from the first quarter of 2000 until December 2004, we had no source of revenue and had to rely on equity infusions to remain in business and maintain the critical employees and assets of the Company until such time that uranium prices reached a level where it was prudent to commence operations. The company began producing at its Vasquez property in South Texas in the fourth quarter of 2004.  Production at Kingsville Dome began in the second quarter of 2006.

The financial statements of the Company have been prepared on the basis of accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

3.DISCLOSURE OF NON-CASH TRANSACTIONS

The following non-cash transaction occurred in the first quarter of 2007 and 2006:

During the first quarter of 2007 and 2006, the Company entered into capital leases to acquire property, plant and equipment items including logging trucks and office computers and equipment totaling $96,000 and $50,000, respectively.  The outstanding balance of the capital leases was $446,000 at March 31, 2007.

In March 2006, 103,896 shares of the Company’s Common Stock were issued in connection with the conversion of the Convertible Notes described in Footnote 8.

4.URANIUM PROPERTIES

Vasquez Project

The Vasquez project commenced production in the fourth quarter of 2004.  Since its start-up and through March 31, 2007, the project has produced 595,400 pounds of uranium. In the first quarter of 2007

7

we produced 44,100 pounds.  As production at Vasquez declines we are beginning preparations for restoration activities at this project and expect to commence with restoration in the third quarter of 2007.

Kingsville Dome Project

We began production from wellfield 13 at Kingsville Dome at the end of January 2007, which was the first new wellfield to be brought on in Production Area Authorization (“PAA”) #3.  Production from wellfield 13 was 48,600 pounds in the first quarter of 2007.  Kingsville Dome produced a total of 64,900 pounds for the quarter.

During the first quarter wellfield delineation and development work has continued on PAA #3 wellfields 14 and 15 at Kingsville Dome.  Production from wellfield 14 is planned for the second quarter of 2007 and wellfield 15 production is expected to begin by early summer 2007.

Rosita/Rosita South

Capital expenditures for our Rosita and Rosita South projects totaled $1.6 million in the first quarter of 2007.  These costs were made to upgrade the Rosita plant and elution circuit and construction of a drying facility at Rosita and for wellfield development at Rosita and wellfield evaluation at Rosita South.  The timing of production from Rosita and Rosita South will be dependent on the results of our drilling program which is expected to be completed in the second quarter of 2007.

5.CONTRACT COMMITMENTS

Amendment to Uranium Sales Contracts

In March 2006 we entered into a new contract with Itochu and a new contract with UG that supersede the previously existing contracts and provide for delivery of one-half of our actual production from our Vasquez property and other properties in Texas currently owned or hereafter acquired by the Company (excluding certain large potential exploration plays). The terms of such contracts are summarized below.

The Itochu Contract. Under the Itochu contract all production from the Vasquez property will be sold at a price equal to the average spot price for the eight weeks prior to the date of delivery less $6.50 per pound, with a floor for the spot price of $37 and a ceiling of $46.50. Other Texas production will be sold at a price equal to the average spot price for the eight weeks prior to the date of delivery less $7.50 per pound, with a floor for the spot price of $37 and a ceiling of $43. On non-Vasquez production the price paid will be increased by 30% of the difference between actual spot price and the $43 ceiling up to and including $50 per pound. If the spot price is over $50 per pound the price on all Texas production will be increased by 50% of such excess. The floor and ceiling and sharing arrangement over the ceiling applies to 3.65 million pounds of deliveries, after which there is no floor or ceiling. Itochu has the right to cancel any deliveries on six-month’s notice.

In December 2005 we entered into a joint venture with Itochu to develop our Churchrock property in New Mexico. See “Joint Venture for Churchrock Property.”  Under the terms of the joint venture, both parties must make an investment decision after the completion of a feasibility study, which was completed at the end of 2006. If Itochu should terminate the venture at that time, we would no longer receive the additional price of 30% of the excess over $43 per pound outlined above. If we should terminate the venture at that time, the original contract terms will be reinstated from that time forward.  The parties have extended the preliminary investment decision until August 1, 2007.

The UG Contract. Under the UG contract all production from the Vasquez property and other Texas production will be sold at a price equal to the month-end long-term contract price for the second month prior to the month of delivery less $6 per pound until (i) 600,000 pounds have been sold in a particular delivery year and (ii) an aggregate of 3 million pounds of Uranium has been sold. After the 600,000 pounds in any year and 3 million pounds total have been sold, UG will have a right of first refusal to purchase other Texas production at a price equal to the average spot price for a period prior to the date of delivery less 4%. In consideration of UG’s agreement to restructure its previously existing contract, we paid UG $12 million in cash with funds raised in our equity offering completed in April 2006.

8

Derivative Financial Instruments

The Company determined that its long-term uranium sales contracts in effect prior to March 2006 met the definition of derivative financial instruments for financial statement reporting purposes.  Changes in the Company’s derivatives represent non-cash charges to earnings for the present value of the loss the Company would incur in the event it would be required to purchase uranium in the spot market to satisfy the delivery obligations under the uranium sales contracts.  The Company has not entered into hedge transactions with respect to its uranium sales contracts.

6.STOCK BASED COMPENSATION

Adoption of SFAS 123(R)

Effective January 1, 2006, the Company adopted the fair value recognition provisions of Statement of Financial Accounting Standard 123(R) “Share-Based Payment” (“SFAS 123(R)”) using the modified prospective transition method. In addition, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 107 “Share-Based Payment” (“SAB 107”) in March, 2005, which provides supplemental SFAS 123(R) application guidance based on the views of the SEC. Under the modified prospective transition method, compensation cost recognized in the quarter ended March 31, 2006 and beyond includes: (a) compensation cost for all share-based payments granted prior to, but not yet vested as of January 1, 2006, based on the grant date fair value estimated in accordance with the original provisions of SFAS No. 123, and (b) compensation cost for all share-based payments granted beginning January 1, 2006, based on the grant date fair value estimated in accordance with the provisions of SFAS 123(R). In accordance with the modified prospective transition method, results for prior periods have not been restated.

The adoption of SFAS 123(R) resulted in stock compensation expense for the three months ended March 31, 2007 and 2006 of $774,000 and $397,000, respectively, to general and administrative expenses. The Company did not recognize a tax benefit from the stock compensation expense because the Company considers it is more likely than not that the related deferred tax assets, which have been reduced by a full valuation allowance, will not be realized.

The Black-Scholes option-pricing model was used to estimate the option fair values. The option-pricing model requires a number of assumptions, of which the most significant are, expected stock price volatility, the expected pre-vesting forfeiture rate and the expected option term (the amount of time from the grant date until the options are exercised or expire). Expected volatility was calculated based upon actual historical stock price movements through the measurement date of the stock option grant. Expected pre-vesting forfeitures were estimated based on actual historical pre-vesting forfeitures over the most recent periods ending March 31, 2007 for the expected option term. The expected option term was estimated based on historical averages over the most recent periods ending March 31, 2007.

No new option grants were made during the three months ended March 31, 2007 or 2006.

Stock Options as of the Three Months Ended March 31, 2007 and 2006

Employee Stock Options

The Company has two stock Incentive Plans for Employees, both of which were approved by the Company’s stockholders.  Under the 1995 Stock Incentive Plan (the “1995 Plan”) 2,600,521 shares may be purchased upon the exercise of outstanding options with exercise prices ranging from $0.76 to $28.50 per share.  No new options may be granted under the 1995 Plan.

Under the Company’s 2004 Stock Incentive Plan (the “2004 Plan”) a total of 1,750,000 shares may be issued upon exercise of options granted under the 2004 Plan. At December 31, 2006 there were outstanding under the 2004 Plan options for the purchase of 1,722,688 shares of Common Stock at exercise prices ranging from $2.97 to $5.19 per share. At December 31, 2006, 500 shares were available for future grants under the 2004 Plan.

9

Employee stock options generally vest ratably over a 3 or 4 year time frame and have a contractual term of 10 years.

Directors Stock Options

On June 19, 2001, the Company granted to certain outside directors options to purchase 75,000 shares of the Company’s Common Stock at an exercise price of $0.88 per share.  All such options were immediately exercisable and will expire June 19, 2011 or 30 days after the holder ceases to be a director of the Company or one year after such holder’s death, whichever occurs first.  These options have not been exercised and 25,000 of these options were cancelled as of March 31, 2007.

On June 2, 2004 the Company adopted the 2004 Directors’ Stock Option Plan (the “2004 Directors’ Plan”). Under the 2004 Directors’ Plan, each non-employee director on the date the Plan was adopted was granted an option to purchase 75,000 shares of Common Stock. Each non-employee Director elected or appointed to the Board of Directors for the first time will be granted an option to purchase 25,000 shares of Common Stock and, each Non-Employee Director shall be granted an option to purchase 25,000 shares either, (a) upon his or her reelection at an annual meeting of the Company’s stockholders or (b) in any calendar year in which an annual meeting of stockholders is not held, on June 1 of such year. In June 2006, the Directors’ Stock Option Plan was amended to increase the initial grants to non-employee Directors to 50,000 shares of Common Stock.  The 2004 Directors’ Plan replaces an earlier plan that expired in 2004. At March 31, 2007, there were outstanding options for the purchase of 2,000 shares under the old plan.  Stock options under the 2004 Directors’ Plan vest ratably over a 4 year time frame and have a contractual term of 10 years.

At the June 2006 and 2005 annual meeting of the stockholders, each of the non-employee directors of the Company was granted an option under the 2004 Directors Plan to purchase 25,000 shares of the Company’s common stock at an exercise price of $5.15 and $1.80 per share, respectively. In June and October 2006 options to purchase 50,000 shares of the Company’s Common Stock were granted to two new non-employee directors of the Company at exercise prices of $5.13 and $2.97, respectively.  The non-employee directors hold options covering 350,000 shares under the 2004 Directors’ Plan at March 31, 2007. At March 31, 2007, 700,000 shares were available for future grants under the 2004 Directors’ Plan.

The following table summarizes stock options outstanding and changes during the three months period ended March 31, 2007:

	Outstanding Options
	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value
Options outstanding at Jan. 1, 2007	4,675,209		$	2.44
Granted	—		—
Exercised	(6,000	)	$	2.96
Canceled or forfeited	(44,325	)	$	12.72
Options outstanding at March 31, 2007	4,624,884		$	2.35	7.64	$	26,845,000
Options exercisable at March 31, 2007	2,560,592		$	2.12	6.99	$	15,452,055

Shares available for grant under the Plans as of March 31, 2007 were 730,500.

10

Stock options outstanding and currently exercisable at March 31, 2007 are as follows:

	Options Outstanding				Options Exercisable
		Weighted Average
	Number of	Remaining			Number of
	Options	Contractual Life	Weighted Average		Options	Weighted Average
Stock Option Plan	Outstanding	(in years)	Exercise price		Exercisable	Exercise Price
1995 Stock Incentive Plan	2,586,196	6.72	$	1.59	1,680,244	$	1.58
2004 Employee Incentive Plan	1,686,688	8.91	3.43		790,974	3.34
Directors Stock Option Plan	2,000	2.48	7.79		1,874	8.30
2004 Directors Plan	350,000	8.30	2.65		87,500	1.25
	4,624,884	7.64	$	2.35	2,560,592	$	2.12

Total estimated unrecognized compensation cost from unvested stock options as of March 31, 2007 was approximately $3.9 million, which is expected to be recognized over a weighted average period of approximately 2 years.

7.ASSET RETIREMENT OBLIGATIONS

The following table shows the change in the balance of the restoration and reclamation liability during the three months ended March 31, 2007:

Reserve for future restoration and reclamation costs beginning of period	$	4,229,193
Additions and changes in cash flow estimates	48,660
Costs incurred	(366,069		)
Accretion expense	50,091
Reserve for future restoration and reclamation costs at end of period	$	3,961,875

8.SHAREHOLDERS’ EQUITY

Convertible Notes

In March 2006, 103,896 shares of the Company’s Common Stock were issued in connection with the conversion of the Convertible Notes described in Footnote 6.

Common Stock Issued Upon Conversion of Options

In February 2007, the Company raised $17,760 of equity through the issuance of 6,000 shares of Common Stock of the Company upon the exercise of outstanding stock options.

The following table details the changes in shareholders equity for the three months ended March 31, 2007:

	Common Stock			Paid-In		Accumulated
	Shares	Amount		Capital		Deficit			Treasury Stock
Balances, December 31, 2006	51,791,339	$	51,829	$	126,252,871	$	(89,525,887	)	$	(9,418	)
Net loss	—	—		—		(1,420,459		)	—
Stock option exercise	6,000	6		17,754		—			—
Stock compensation expense	—	—		773,672		—			—
Balances, March 31, 2007	51,797,339	$	51,835	$	127,044,297	$	(90,946,346	)	$	(9,418	)

9.ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES

On January 1, 2007, we adopted FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statements No. 109” (“FIN 48”). FIN 48 clarifies the accounting for uncertainty in income taxes by prescribing a two-step method of first evaluating whether a tax position

11

has met a more likely than not recognition threshold and second, measuring that tax position to determine the amount of benefit to be recognized in the financial statements. FIN 48 provides guidance on the presentation of such positions within a classified statement of financial position as well as on derecognition, interest and penalties, accounting in interim periods, disclosure, and transition.

As a result of the implementation of FIN 48, we recognized no change in our recorded assets or liabilities for unrecognized income tax benefits. Based on our analysis of all material tax positions taken, management believes the technical merits of these positions are justified and expects that the full amount of the deductions taken and associated tax benefits will be allowed.

FIN 48 requires the evaluation of a tax position as a two-step process. We must determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation processes, based on the technical merits of the position. If the tax position meets the “more likely than not” recognition threshold, then the tax benefit is measured and recorded at the largest amount that is greater than 50 percent likely of being realized upon ultimate settlement. The re-assessment of our tax positions in accordance with FIN 48 did not result in any material change to our financial condition, results of operations or cash flows.

We have also assessed the classification of interest and penalties, if any, related to income tax matters. Pursuant to the application of FIN 48, we have made an accounting election to treat interest and penalties related to income tax matters, if any, as a component of income tax expense rather than other operating expenses.

10.Impact of Recent Accounting Pronouncements

Fair Value Measurements. In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements,” which provides a common definition for the measurement of fair value for use in applying generally accepted accounting principles in the United States of America and in preparing financial statement disclosures. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007. We are evaluating the effect of the adoption and implementation of SFAS No. 157, which is not expected to have a material impact on our financial condition, results of operations or cash flows.

Fair Value Option for Financial Assets and Liabilities. In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities,” which permits entities to choose to measure many financial instruments and certain other items at fair value. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. We are evaluating the effect of the adoption and implementation of SFAS No. 159, which is not expected to have a material impact on our financial condition, results of operations or cash flows.

12

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

The following summary is qualified in its entirety by, and should be read in conjunction with, the more detailed information and any financial data incorporated herein by reference to the Company’s reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934. Except for historical information contained in this report, the matters discussed herein contain forward-looking statements, made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including management’s expectations regarding the Company’s reserves and mineralized uranium materials, timing of receipt of mining permits, production capacity of mining operations planned for properties in South Texas and New Mexico and planned dates for commencement of production at such properties. Such forward-looking statements are inherently uncertain, and investors must recognize that actual results may differ from management’s expectations. Key factors impacting current and future operations of the Company include the price of uranium, weather conditions, operating conditions at the Company’s mining projects, government regulation of the mining industry and the nuclear power industry, the world-wide supply and demand of uranium, availability of capital, timely receipt of mining and other permits from regulatory agencies and other matters indicated in “Cautionary Statement,” found in the Company’s Annual Report.

Financial Condition and Results of Operations

Comparison of Three Months Ended March 31, 2007 and 2006

Production. In the first three months of 2007 we produced 109,000 pounds.  The Vasquez project produced 44,100 pounds and Kingsville Dome produced 64,900 pounds.  Production in the first three months of 2006 was 55,400, all of which was produced from the Vasquez project.

Uranium  Sales. In the first three months of 2007 we sold 79,700 pounds compared to sales of 65,600 pounds in the same period of 2006.  In the first three months of 2007 we had revenues of $4.6 million ($57.41 per pound) compared to $1.1 million ($16.29 per pound) in the first three months of 2006.  The increase in the sales revenue per pound in 2007 resulted from higher prices received under new contracts entered into with each of our two customers in March 2006 which superseded the previous contracts.

Cost of Uranium Sales.  Our cost of uranium sales from the sale of produced uranium in the first quarter of 2007 was $3.9 million ($48.74 per pound) compared to $2.4 million in the first quarter of 2006 ($35.86 per pound), excluding the gain on derivatives of $34.3 million recorded in connection with the revised uranium sales contracts  in March 2006.

 Operating expenses per pound decreased to $22.43 per pound in the first quarter of 2007 compared to $23.22 per pound in the first quarter of 2006.  Royalties and commissions in first quarter of 2007 increased to $5.51 per pound compared to $1.21 per pound in the first quarter of 2006 as a result of the increased sales prices we received in 2007 compared to 2006.  Depreciation and depletion in the first quarter of 2007 increased to $18.66 per pound compared to $9.40 per pound for the first quarter of 2006.  The first quarter of 2006 included only Vasquez production, while 2007 included production from the first two wellfields at Kingsville Dome which was produced a higher capital cost than experienced in the first quarter of 2006 at Vasquez.  Accretion and amortization of future restoration costs was $170,000 in the first quarter of 2007 compared to $133,000 in the first quarter of 2006.

General and Administrative Charges.  We incurred general and administrative charges and corporate depreciation of $2.2 million in the first three months of 2007 compared to $1.1 million for the same period in 2006.

Significant expenditures for general and administrative expenses for the three months ended March 31, 2007 and 2006 were:

13

	2007		2006
Stock compensation expense	$	774,000	$	397,000
Salaries and payroll burden	551,000		300,000
Legal, accounting, public company expenses	407,000		156,000
Insurance and bank fees	111,000		85,000
Consulting and professional services	190,000		58,000
Office expenses	89,000		41,000
Travel expenses	57,000		24,000
Other, project allocations	33,000		(5,000		)
Total	$	2,212,000	$	1,056,000

The non-cash compensation expense recorded for the three months ended March 31, 2007 and 2006 resulted from the adoption of SFAS 123(R) in January 2006, requiring the recognition of expense related to the Company’s stock option grants.

Salary and payroll costs increases for the three months presented resulted primarily from the additions to the engineering, professional and executive levels in South Texas and New Mexico made in 2007 and 2006 and compensation increases for the Company’s key personnel in the second half of 2006.

The Company’s legal, accounting and public company expenses increased in 2007 from audit and consulting fees related to Sarbanes-Oxley compliance, increased legal fees related to the finalization of our NASDAQ listing and the increase in the Company’s Board of Directors membership in late 2006 and an increase in Board and Committee meetings in 2007.

Our insurance costs increased in the three month period from higher directors and officer’s insurance premiums, higher cost of property and casualty coverage and increased vehicle coverage premiums resulting from additional vehicles in 2007.

The costs for consulting and professional services increased in the three month period as a result of an increase in project related activities in 2007.  Such activities include increased in activities in New Mexico related to work performed in the review and assessment of our New Mexico property data bases to evaluate their potential as  conventional mining projects, New Mexico costs related to the preparation of ISR projects towards their final licensing and permitting phase, increases in environmental, health and safety training, the engagement of an investor relations and media relations firm in late 2006 and consulting work and computer networking and web site design work.

Increased office costs incurred in the three months resulted primarily from the opening of a corporate office location in Corpus Christi, Texas in June 2006, increases in the South Texas Kingsville operations office resulting from the personnel added in 2006 and additions made to the Crownpoint office in New Mexico to support the additional activities in the first quarter of 2007.

Net Earnings and Losses. For the three months ended March 31, 2007 and 2006, we had a net loss of $1.4 million and net earnings of $32.2 million, respectively.  The earnings in 2006 included a non-cash gain on derivatives of $34.3 million.

Cash Flow.  As of March 31, 2007 we have a cash balance of approximately $16.6 million compared to $465,000 at the same date in 2006.

In the first three months of 2007, we had positive cash flow from operations of $730,000, resulting primarily from the increased price received under our uranium sales contracts that were amended in March 2006.  We also used $4.3 million in investing activities for wellfield development and evaluation drilling capital at Kingsville Dome of $1.8 million, additional wellfield development at Vasquez of $249,000, Rosita and Rosita South project expenditures of $1.1 million and $540,000, other Texas property and other assets of $358,000 and other property additions in New Mexico of $244,000.

14

In the first quarter of 2006, we had a negative cash flow from operations of ($290,000) and used $5.1 million in investing activities primarily for production start-up capital at Kingsville Dome of $3.3 million additional wellfield development at Vasquez and other plant and equipment additions of $1.4 million.

Liquidity—Cash Sources and Uses for 2007

In the first three months of 2007 our net cash outflows have averaged $1.2 million per month. Our cash balance at March 31, 2007 was $16.6 million and based upon our current plan of operations we anticipate that our operating and capital requirements for 2007 will be met through existing cash and cash generated from operations.

Contingent Liabilities—Off Balance Sheet Arrangements

In April 2006, the Company completed the sale of 10,200,307 shares of its Common Stock at $4.90 per share to accredited investors resulting in gross proceeds of approximately $50 million before expenses of the offering.  The Company has filed a registration statement under the Securities Act of 1933, as amended, to register the resale of the shares.  Such shares are subject to certain resale registration rights that include penalties (1% per month) in the event registration statement does not become effective in a timely manner or if the registration statement fails to remain effective.  On August 4, 2006, such registration statement was made effective and the Company met its initial obligation.  We have periodically updated the registration statement as necessary to ensure that the registration statement has continued to remain effective.

The Company has obtained financial surety relating to certain of its future restoration and reclamation obligations as required by the State of Texas regulatory agencies. The Company has bank Letters of Credit (the “L/C’s) and performance bonds issued for the benefit of the Company to satisfy such regulatory requirements. The L/C’s were issued by Bank of America and the performance bonds have been issued by United States Fidelity and Guaranty Company (“USF&G”). L/C’s for $2.1 million and $2.0 million were issued at March 31, 2007 and December 31, 2006, respectively, such L/C’s are collateralized in their entirety by certificates of deposit.

Performance bonds totaling $2.8 million were issued for the benefit of the Company at March 31, 2007 and December 31, 2006. USF&G has required that the Company deposit funds collateralizing a portion of the bonds. The amount of bonding issued by USF&G exceeded the amount of collateral by $2.5 million at March 31, 2007 and December 31, 2006, respectively. In the event that USF&G is required to perform under its bonds or the bonds are called by the state agencies, the Company would be obligated to pay any expenditure in excess of the collateral.

Critical Accounting Policies

Our significant accounting policies are described in Note 2 to the consolidated financial statements included in the Company’s 2006 Annual Report on Form 10-K/A.  We believe our most critical accounting policies involve those requiring the use of significant estimates and assumptions in determining values or projecting future costs.

Specifically regarding our uranium properties, significant estimates were utilized in determining the carrying value of these assets. These assets have been recorded at their estimated net realizable value for impairment purposes on a liquidation basis, which is less than our cost. The actual value realized from these assets may vary significantly from these estimates based upon market conditions, financing availability and other factors.

Regarding our reserve for future restoration and reclamation costs, significant estimates were utilized in determining the future costs to complete the groundwater restoration and surface reclamation at our mine sites.  The actual cost to conduct these activities may vary significantly from these estimates.

Such estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

15

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Uranium Price Volatility

The Company is subject to market risk related to the market price of uranium.  The Company’s cash flow has historically been dependent on the price of uranium, which is determined primarily by global supply and demand, relative to the Company’s cost of production.  Historically, uranium prices have been subject to fluctuation, and the price of uranium has been and will continue to be affected by numerous factors beyond the Company’s control, including the demand for nuclear power, political and economic conditions, governmental legislation in uranium producing and consuming countries and production levels and costs of production of other uranium producing companies.

Derivative Financial Instruments

The Company determined that its long-term uranium sales contracts in effect prior to March 2006 met the definition of derivative financial instruments for financial statement reporting purposes.  Changes in the Company’s derivatives represent non-cash charges to earnings for the present value of the loss the Company would incur in the event it would be required to purchase uranium in the spot market to satisfy the delivery obligations under the uranium sales contracts.  The Company has not entered into hedge transactions with respect to its uranium sales contracts.

The Company amended these contracts in March 2006.  The amended contracts obligate the Company to deliver 50% of its uranium production to each customer, and do not obligate the Company to deliver any uranium in excess of its production.  The Company has determined that the terms of the amended contracts eliminates their qualification as derivatives and therefore are not required to be valued at fair value.

ITEM 4.CONTROLS AND PROCEDURES

During the the year ended December 31, 2006 and the quarter ended March 31, 2007, the Company’s management, with the participation of the Chief Executive Officer and Chief Financial Officer of the Company, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)).

Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of December 31, 2006 and March 31, 2007 were not effective as a result of the material weakness in our internal controls over financial reporting discussed below.

Management’s Report on Internal Control over Financial Reporting

The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting. The Securities and Exchange Act of 1934 defines internal control over financial reporting in Rule 13a-15(f) and 15d-15(f) as a process designed by, or under the supervision of, the company’s principal executive and principal financial officers and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

·Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;

·Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and

16

·Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

The Company’s management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2006 and March 31, 2007. In making this assessment, the Company’s management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting in connection with preparation of the annual report on Form 10-K for the year ended December 31, 2006 and March 31, 2007. As a result of these assessments, a material weakness was identified in March 2007, in connection with our year ended December 31, 2006 audit procedures, leading management to conclude that our internal controls over financial reporting were not effective as of December 31, 2006. A material weakness is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected.

The following material weakness forms the basis for our conclusion at December 31, 2006 and March 31, 2007:

·   Controls over the Review of Financial Statements. Our financial and accounting organization consists of the Vice President—Finance and the Corporate Controller. Due to a lack of financial and accounting resources, the financial records preparation and review procedures performed by our personnel with respect to our application of the fair value recognition provisions of Statement of Financial Accounting Standard 123(R) ” Share-Based Payment” (“SFAS 123(R)”) for the fourth quarter of 2006 did not correctly record certain terms of stock option grants made in the fourth quarter of 2006. This matter was identified by our auditors in March 2007 during the course of their audit procedures and resulted in an audit adjustment increasing stock compensation expense by $629,000 in our year end 2006 financial statements. Because of this lack of resources, review procedures were not consistently performed on a timely basis to ensure that financial reporting and fraud risk controls were operating in the manner designed.

Changes in Internal Controls

There were no changes in our internal control over financial reporting during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  Management is currently evaluating the implementation of procedures that may be necessary to fully remediate the material weakness described above. Management is in the process of making the following changes to its system of internal controls:

·   We are planning for a relocation and expansion of our corporate office in the second quarter of 2007, which will allow for the hiring of additional personnel, including both experienced accounting and support staff to allow for improved segregation of duties and allow for a more thorough review, by senior financial personnel, of the financial statements and underlying supporting documentation. In March and April 2007, we contacted various search firms specializing in the accounting and financial services areas to identify and recruit qualified personnel. We are in the process of reviewing potential candidates to expand our internal accounting resources.

·   The addition of accounting and support staff will allow for the formal documentation of our purchasing and procurement policies and permit the implementation of review procedures at each uranium project location and in the financial reporting area for compliance with such policies.

17

PART II - OTHER INFORMATION

ITEM 1.LEGAL PROCEEDINGS

No change from the prior annual filing on our Form 10-K/A.

ITEM 1A.RISK FACTORS

Over 65.2% of our shares of Common Stock is controlled by Principal Stockholders and Management.

Over 56.0% of our Common Stock is controlled by five stockholders of record. In addition, our directors and officers are the beneficial owners of about 9.2% of our Common Stock. This includes with respect to both groups shares that may be purchased upon the exercise of outstanding options. Such ownership by the Company’s principal shareholders, executive officers and directors may have the effect of delaying, deferring, preventing or facilitating a sale of the Company or a business combination with a third party.

The availability for sale of a large amount of shares may depress the market price for our Common Stock.

As of December 31, 2006 and March 31, 2007, we identified a material weakness in internal control over financial reporting and concluded that our disclosure controls were not effective. If we fail to maintain an effective system of internal and disclosure controls, we may not be able to accurately report our financial results or prevent fraud. As a result, investors may be misled and lose confidence in our financial reporting and disclosures and the price of our common stock may be negatively affected.

The Sarbanes-Oxley Act of 2002 requires that we report annually on the effectiveness of our internal control over financial reporting. Among other things, we must perform systems and process evaluation and testing. We must also conduct an assessment of our internal controls to allow management to report on, and our independent registered public accounting firm to attest to, our assessment of our internal control over financial reporting as required by Section 404 of the Sarbanes-Oxley Act.

In connection with the assessment of our internal control over financial reporting for our Annual Report on Form 10-K/A, as further described in Item 9A of such Form 10K/A, management and our registered public accounting firm determined that as of December 31, 2006 and March 31, 2007 our disclosure controls and procedures were ineffective because of the material weakness in our internal control over financial reporting.

Although we have made and are continuing to make improvements in our internal controls, if we are unsuccessful in remediating the material weakness impacting our internal control over financial reporting and disclosure controls, or if we discover other deficiencies, it may adversely impact our ability to report accurately and in a timely manner our financial condition and results of operations in the future, which may cause investors to lose confidence in our financial reporting and may negatively affect the price of our Common Stock. Moreover, effective internal and disclosure controls are necessary to produce accurate, reliable financial reports and to prevent fraud. If we continue to have deficiencies in our internal control over financial reporting and disclosure controls, they may negatively impact our business and operations.

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

18

ITEM 3.DEFAULTS UPON SENIOR SECURITIES.

None

ITEM 4.SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None

ITEM 5.OTHER INFORMATION.

None

ITEM 6.EXHIBITS

See the Index to Exhibits on Page E-1 for a listing of the exhibits that are filed as part of this Quarterly Report.

19

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	URANIUM RESOURCES, INC.
Dated: May 10, 2007	By:	/s/ Paul K. Willmott
		Paul K. Willmott
		Director and
		Chief Executive Officer
Dated: May 10, 2007	By:	/s/ Thomas H. Ehrlich
		Thomas H. Ehrlich
		Vice President - Finance and
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

20

EXHIBIT INDEX

Exhibit Number	Description
3.1*	Restated Certificate of Incorporation of the Company, dated February 15, 2004 (filed with the Company’s Registration Statement on Form SB-2 dated July 26, 2004, SEC File Number 333-117653).
3.1.1*	Certificate of Amendment of Restated Certificate of Incorporation of the Company (filed with the Company’s Form 8-K dated April 11, 2006, SEC File Number 000-17171).
3.2*	Restated Bylaws of the Company (filed with the Company’s Form 8-K on April 14, 2005).
4.1*	Common Stock Purchase Agreement dated February 28, 2001 between the Company and Purchasers of the Common Stock of the Company (filed with the Company’s Annual Report on Form 10-KA dated July 26, 2001, SEC File Number 000-17171).
10.1*	Amended and Restated Directors Stock Option Plan (filed with the Company’s Form S-8 Registration No. 333- 00349 on January 22, 1996).
10.2*	Amended and Restated Employee’s Stock Option Plan (filed with the Company’s Form S-8 Registration No. 333-00403 on January 24, 1996).
10.3*	Amended and restated 1995 Stock Incentive Plan (filed with the Company’s Form SB-2 Registration No. 333-117653 on July 26, 2005).
10.4*	Non-Qualified Stock Option Agreement dated June 19, 2001 between the Company and Leland O. Erdahl (filed with the Company’s 10-QSB dated August 13, 2001, SEC File Number 000-17171).
10.5*	Non-Qualified Stock Option Agreement dated June 19, 2001 between the Company and George R. Ireland (filed with the Company’s 10-QSB dated August 13, 2001, SEC File Number 000-17171).
10.7*	Summary of Supplemental Health Care Plan (filed with Amendment No. 1 to the Company’s Form S-1 Registration Statement (File No. 33-32754) as filed with the Securities and Exchange Commission on February 20, 1990).
10.9*	License to Explore and Option to Purchase dated March 25, 1997 between Santa Fe Pacific Gold Corporation and Uranco, Inc. (filed with the Company’s Annual Report on Form 10-K dated June 30, 1997, SEC File Number 000-17171).
10.12*	Compensation Agreement dated June 2, 1997 between the Company and Paul K. Willmott (filed with the Company’s Annual Report on Form 10-K dated June 30, 1998, SEC File Number 000-17171).
10.13*	Compensation Agreement dated June 2, 1997 between the Company and Richard A. Van Horn (filed with the Company’s Annual Report on Form 10-K dated June 30, 1998, SEC File Number 000-17171).
10.14*	Compensation Agreement dated June 2, 1997 between the Company and Thomas H. Ehrlich (filed with the Company’s Annual Report on Form 10-K dated June 30, 1998, SEC File Number 000-17171).
10.15*	Compensation Agreement dated June 2, 1997 between the Company and Mark S. Pelizza (filed with the Company’s Annual Report on Form 10-K dated June 30, 1998, SEC File Number 000-17171).

10.16*	Uranium Resources, Inc. 1999 Deferred Compensation Plan (filed with the Company’s Annual Report on Form 10-K dated June 30, 1999, SEC File Number 000-17171).
10.16.1*	Amendment No. 1 to the Uranium Resources, Inc. 1999 Deferred Compensation Plan (filed with the Company’s Annual Report on Form 10KSB dated March 31, 2006, SEC File Number 000-17171).
10.17*	2000-2001 Deferred Compensation Plan (filed with the Company’s Annual Report on Form 10-K dated December 31, 2004, SEC File Number 000-17171).
10.17.1*	Amendment No. 2 to the Uranium Resources, Inc. Deferred Compensation Plan for 2000-2001 (filed with the Company’s Annual Report on Form 10KSB dated March 31, 2006, SEC File Number 000-17171).
10.22*	Uranium Resources, Inc. Deferred Compensation Plan for 2002 (filed with the Company’s Quarterly Report on Form 10-QSB dated November 13, 2002, SEC File Number 000-17171).
10.23*	Uranium Resources, Inc. Deferred Compensation Plan for 2003 (filed with the Company’s Quarterly Report on Form 10-QSB dated November 13, 2002, SEC File Number 000-17171).
10.24*	Uranium Resources, Inc. Deferred Compensation Plan for 2004 (filed with the Company’s Quarterly Report on Form 10-QSB dated May 14, 2004, SEC File Number 000-17171).
10.24.1*	Amendment No. 2 to the Uranium Resources, Inc. Deferred Compensation Plan for 2002, Deferred Compensation Plan for 2003, and Deferred Compensation Plan for 2004 (filed with the Company’s Annual Report on Form 10-KSB dated March 31, 2006, SEC File Number 000-17171).
10.27*	Contract with UG U.S.A., Inc for the Purchase of Natural Uranium Concentrates (U3O8) dated August 12, 2003 (filed with the Company’s Pre-Effective Amendment No. 2 to Registration Statement on form SB-2 dated September 20, 2005, SEC File Number 333-125106).
10.27.1*	Amendment No. 1 with UG U.S.A., Inc. dated August 30, 2004 to Exhibit 10.27 (filed with the Company’s Pre-Effective Amendment No. 2 to Registration Statement on form SB-2 dated September 20, 2005, SEC File Number 333-125106).
10.27.2*	Amendment No. 2 with UG U.S.A., Inc. dated April 29, 2005 to Exhibit 10.27 (filed with the Company’s Pre-Effective Amendment No. 2 to Registration Statement on form SB-2 dated September 20, 2005, SEC File Number 333-125106).
10.28*	Amended and Restated Uranium Supply Contract with Itochu Corporation dated June 7, 2005 (filed with the Company’s Pre-Effective Amendment No. 2 to Registration Statement on form SB-2 dated September 20, 2005, SEC File Number 333-125106).
10.31*	Note Purchase Agreement dated March 24, 2005 and promissory notes issued thereunder (filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 2004, SEC File Number 000-17171).
10.32*	Uranium Supply Contract with UG U.S.A., Inc. dated April 29, 2005 (filed with the Company’s Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 dated September 20, 2005, SEC File Number 333-125106).

10.33*	Uranium Supply Contract with Itochu Corporation dated June 15, 2005 (filed with the Company’s Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 dated September 20, 2005, SEC File Number 333-125106).
10.34*	Stock Purchase Agreement by and between Uranium Resources, Inc. and accredited investors (filed with the Company’s Form 8-K dated August 12, 2005, SEC File No. 000-17171).
10.35*	Uranium Resources, Inc. 2004 Stock Incentive Plan (filed with the Company’s Quarterly Report on Form 10QSB/A dated November 18, 2005, SEC File No. 000-17171).
10.36*	Feasibility Study Funding Agreement between Itochu Corporation, Uranium Resources, Inc. and Hydro Resources, Inc. effective March 29, 2006. (filed with the Company’s Form 10KSB dated March 31, 2006, SEC file Number 000-17171).
10.37*	Amended and Restated Uranium Supply Contract between Itochu Corporation and Uranium Resources, Inc. effective March 1, 2006. (filed with the Company’s Form 10KSB dated March 31, 2006, SEC file Number 000-17171).
10.38*	Agreement for the Sale of Uranium Concentrates between UG U.S.A., Inc. and Uranium Resources, Inc. dated March 31, 2006. (filed with the Company’s Form 10KSB dated March 31, 2006, SEC file Number 000-17171).
10.39*	Stock Purchase Agreement dated as of April 19, 2006, by and between Uranium Resources, Inc. and accredited investors (filed with the Company’s Current Report on Form 8-K dated April 19, 2006, SEC File No. 000-17171).
10.40*	Limited Liability Company Agreement of Churchrock Venture LLC (filed with the Company’s Current Report on Form 8-K dated December 5, 2006, SEC File No. 000-17171).
10.41*	Compensation Agreement dated March 12, 2007 between the Company and Craig S. Bartels (filed with the Company’s Form 8-K dated March 13, 2007, SEC File No. 000-17171).
10.42*	Compensation Agreement dated March 12, 2007 between the Company and David N. Clark (filed with the Company’s Form 8-K dated March 13, 2007, SEC File No. 000-17171).
10.43*	Amended and Restated 2004 Directors’ Stock Option Plan dated April 10, 2007 (filed with the Company’s Post-Effective Amendment No. 1 to Registration Statement on Form S-3 dated April 11, 2007, SEC File No. 333-133960).
10.44	Uranium Resources, Inc. 2007 Restricted Stock Plan.
14*	Uranium Resources, Inc. Code of Ethics for Senior Executives. Filed with the Company’s Annual Report on Form 10-KSB dated March 30, 2004, SEC File Number 000-17171).
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

* Not filed herewith. Incorporated by reference pursuant to Rule 12b-32 under the Securities Exchange Act of 1934.

EX-10.44

Exhibit 10.44

URANIUM RESOURCES, INC.

2007 RESTRICTED STOCK PLAN

General.  This 2007 Restricted Stock Plan (the “Plan”) provides eligible employees of Uranium Resources, Inc. (the “Company”) and its subsidiary corporations with the opportunity to increase their ownership interest in the Company through the receipt of restricted shares of Common Stock, par value $.001 per share, of the Company (“Restricted Stock”) granted and issued by the Company, from time to time, subject to the terms and conditions of the Plan.   Any such grants of Restricted Stock made to eligible employees are subject to the provisions and limitations of Section 162(m) of the Internal Revenue Code of 1986 as amended (the “Code”).

1.Purpose of the Plan.  The purpose of the Plan is to retain and motivate the managers and key employees of the Company, and of any subsidiary corporation of the Company, by enabling such managers and key employees to acquire new or additional stock ownership in the Company, thereby increasing their proprietary interest in the Company’s business and enhancing their mutual and personal interest in the Company’s success.  For purposes of the Plan, a “subsidiary corporation” consists of any corporation at least fifty percent (50%) of whose voting power (taking into account all classes of stock) is directly or indirectly owned by the Company.

2.Effective Date of the Plan.  The Plan shall become effective upon its adoption by the Board of Directors, subject to approval by the stockholders of the Company.  If the Plan is so approved, no further approval shall be required with respect to the administration of grants made pursuant to the Plan (except as provided in Section 9 and Section 10 hereof).

3.Administration of the Plan.  The Plan shall be administered by the Compensation Committee of the Board of Directors of the Company, or by a committee comprised of at least two (2) directors selected by such Board of Directors (for Plan purposes, the “Committee”).  A member of the Committee shall not be eligible to participate in the Plan while serving on the Committee.

A majority of the Committee shall constitute a quorum.  The acts of a majority of the members present at any meeting at which a quorum is present (or acts approved in writing by all members of the Committee) shall constitute binding acts of the Committee.

Subject to the terms and conditions of the Plan, the Committee shall be authorized and empowered:

(a)To select the managers and key employees to whom grants may be made;

(b)To determine the time or times when shares of Restricted Stock will be granted, and the number of shares to be covered by any grant;

(c)To prescribe the terms and conditions of any grants made under the Plan, and the forms and agreements used in connection with such grants;

(d)To determine the time or times when Restricted Stock will vest upon the attainment of personal service or performance standards pertaining to such Restricted Stock, and determine the legends or markings to be placed upon stock certificates representing any such shares to reflect such standards and restrictions;

(e)To determine the time or times during which such Restricted Stock grants may be  terminated in whole or in part, or when any such grants may be otherwise subject to forfeiture; and

(f)To establish any other Restricted Stock agreement provisions not inconsistent with the terms and conditions of the Plan;

A-1

4.Employees Eligible for Grants.  Grants may be made from time to time to those managers and key employees of the Company or any subsidiary corporation, who are designated by the Committee in its sole and exclusive discretion (individually, a “Grantee”; collectively, the “Grantees”).  Grantees may include, but shall not necessarily be limited to officers of the Company and officers of subsidiary corporations.  The Committee may make more than one Restricted Stock grant to the same Grantee, and the provisions of Restricted Stock grants need not be the same with respect to each Grantee.  No shares of Restricted Stock shall be granted to any manager or key employee during any period of time when such manager or key employee is on an unpaid leave of absence.

5.Shares Subject to the Plan.  The Company’s common stock, par value $.001 per share (“Common Stock”) shall be used to make grants of Restricted Stock under the Plan.  Either Common Stock held as treasury stock, or authorized and unissued Common Stock, or both, may be used to make Restricted Stock grants (as determined by the Board of Directors of the Company), subject only to the maximum limits of the Plan.

Subject to the provisions of the next succeeding paragraph of this Section, no more than one million, five hundred thousand (1,500,000) shares of Common Stock can be issued under the Plan.  The number of shares of Restricted Stock which may be granted to any manager or key employee in any calendar year may not exceed five hundred thousand (500,000) shares.

If, at any time subsequent to the date of adoption of the Plan by the Board of Directors, Common Stock is eliminated as a class, or the number of shares of Common Stock outstanding increases or decreases, as a result of a stock split, stock dividend, combination or exchange of shares, exchange for other securities, reclassification, reorganization, redesignation, merger, consolidation, recapitalization, or similar restructuring, reorganization or corporate event, there shall automatically be substituted for each share of Restricted Stock granted under the Plan (to the extent not yet vested as of the date of such elimination, increase or decrease), the number and kind of shares of stock or other securities into which each outstanding share of Common Stock is to be changed or for which each such share of Common Stock is to be exchanged.  In addition to the foregoing, the Committee shall be entitled in the event of any such increase, decrease or exchange of shares of Common Stock to make other adjustments to the securities subject to a Restricted Stock grant, the provisions of the Plan, and to any related Restricted Stock agreements (including adjustments which may provide for the elimination of fractional shares) where necessary to preserve the terms and conditions of any grants hereunder.

6.Restricted Stock Provisions.

(a)Shares of Restricted Stock may be granted either alone or in addition to any other compensation paid outside of the Plan.  The prospective recipient of a Restricted Stock grant shall not have any rights with respect to such grant unless and until such recipient has entered into a written Restricted Stock Grant Agreement with the Company evidencing such grant, has delivered a fully executed copy thereof to the Company, and has otherwise complied with the applicable terms and conditions of such grant.

(b)To be enforceable, a grant of Restricted Stock must be accepted within a period of 60 days (or such shorter period as the Committee may specify at grant) following the grant date; acceptance shall be evidenced by executing an approved Restricted Stock Grant Agreement.   Upon acceptance of a grant of Restricted Stock, a Grantee shall be issued a stock certificate in respect of such shares of Restricted Stock.  Such certificate shall be registered in the name of such Grantee, and shall bear an appropriate legend identifying the terms, conditions, and restrictions applicable to such grant.

(c)The Committee shall require that: (i) the stock certificates evidencing shares of Restricted Stock be held in the custody of the Company or its designee until the restrictions thereon shall have lapsed, and (ii) as a condition of any Restricted Stock grant, the Grantee shall

A-2

have delivered a stock power, endorsed in blank, relating to the Restricted Stock covered by such grant.

(d)Subject to the provisions of the Plan and the Restricted Stock Grant Agreement, during the period set by the Committee commencing with the date of such grant and the date or circumstances under which all restrictions lapse  (the “Restriction Period”), a Grantee shall not be able to sell, transfer, pledge, anticipate or assign Restricted Stock.  Unless otherwise specified by the Committee, the Restricted Period shall not be less than five years. The Committee shall condition any lapse of the Restricted Period upon the attainment of specified personal service  and/or performance standards specified by the Committee at the time of grant; such standards may include, but shall not be limited to, the attainment of financial performance goals, the attainment or maintenance of specified prices for Common Stock, the attainment of a cumulative earnings per share or an indicated return on equity.  In addition to the foregoing, the Committee may condition the vesting of Restricted Stock on such other factors as the Committee may determine and specify, acting in its sole discretion.  Subject to the foregoing limitations, the Committee, in its sole discretion, may also specify that a Restricted Period may lapse in installments, or that the restrictions contained in a Restricted Stock grant are to be waived or accelerated in whole or in part based on the attainment of additional personal service or performance standards specified by  the Committee, acting in its sole discretion.

(e)Except as provided in Section 7 and Section 8 of this Plan, a Grantee shall have, with respect to the shares of Restricted Stock, all of the rights of a stockholder of the Company, including the right to vote such Stock and the right to receive any regular cash dividends paid out of current earnings in respect of such Stock.  The Committee, in its sole discretion, as determined at the time of grant, may permit or require any cash dividends paid in respect of Restricted Stock to be reinvested in additional Restricted Stock, to the extent shares are available under Section 5 of the Plan  Stock dividends, splits and distributions issued with respect to Restricted Stock shall be treated as additional shares of Restricted Stock that are subject to the same restrictions and other terms and conditions that apply to the Restricted Stock with respect to which such dividends are declared and paid, and the Committee may require a Grantee to deliver additional stock powers covering any Restricted Stock issuable pursuant to such stock dividend, split or distribution.  Any other dividends paid or property distributed in respect of Restricted Stock, other than regular dividends declared and paid out of current earnings, shall be held by the Company subject to the same restrictions imposed upon the Restricted Stock to which such dividends and/or property relates.

(f)Subject to the applicable provisions of the Restricted Stock Grant Agreement and Section 7 of this Plan, upon termination of a Grantee’s employment with the Company or subsidiary corporation (as applicable) for any reason during the Restriction Period, all Restricted Stock then held by or in respect of such Grantee will vest, or be forfeited (as applicable) in accordance with the terms and conditions of the Plan, subject to any subsequent determinations made by the Committee.

(g)If and when the Restriction Period applicable to Restricted Stock expires without a prior forfeiture of such Stock, such Stock shall be released to the Grantee by the Company (or its designee), together with any other property held by the Company with respect to such Stock, and an appropriate stock certificate shall be promptly delivered to the Grantee evidencing unrestricted ownership of such Stock.

7.Termination of Employment.  If a Grantee ceases to be an employee of the Company or subsidiary corporation (as applicable), for any reason other than death, normal or early retirement under the terms of the Company’s pension and profit-sharing plans, or permanent and total disability, any  Restricted Stock held in respect of such Grantee which has not yet vested shall, unless otherwise determined by the Committee on or before the date of such Grantee’s termination of employment, be forfeited as of  the effective date of such termination.  Neither the Grantee nor any other person shall have any right after such date to any part of any Restricted Stock so forfeited.

A-3

If a Grantee’s termination of employment is due to death, normal or early retirement under the Company’s pension or profit-sharing plans, or permanent and total disability, then such Grantee’s Restricted Stock shall fully vest (to the extent not already vested) upon the date of any such termination of employment and all applicable restrictions thereon shall lapse and expire.  In the case of death, any Restricted Stock held by the Company or its designee shall be transferred and released to such Grantee’s estate, or the person designated by such Grantee by will or in accordance with relevant state law.

In the event a Grantee takes or is granted a leave of absence approved by the Company or such subsidiary corporation, or is entitled to and takes a leave of absence by operation of law (whether to perform\ military service, or as a result of sickness or injury, or otherwise), such Grantee’s employment with the Company or such subsidiary corporation shall not be considered terminated for Plan purposes.  Rather, such Grantee shall be treated for Plan purposes as an ongoing employee of the Company or such subsidiary corporation (as applicable) during such leave of absence.

8.Change of Control.  Upon the occurrence of a Change of Control (as defined in this Section), notwithstanding any other Plan provision or any agreement to the contrary, any and all Restricted Stock granted under the Plan shall immediately and fully vest (to the extent not theretofore vested), and all application restrictions thereon shall lapse and expire.

For purposes of the Plan, a Change of Control shall be deemed to have occurred if:  (i) a tender offer shall be made and consummated for the ownership of 25% or more of the outstanding voting  securities of the Company; or (ii) the Company shall be merged or consolidated with another corporation and, as a result of such merger or consolidation, less than 75% of the outstanding voting securities of the surviving or resulting corporation shall be owned in the aggregate by the former stockholders of the Company as the same shall have existed immediately prior to such merger or consolidation; or (iii) the Company shall sell substantially all of its assets to another corporation which is not a wholly owned subsidiary; or (iv) a person, within the meaning of Section 3(a)(9) or of Section 13(d)(3) (as in effect on the date hereof) of the Exchange Act, shall acquire, other than by reason of inheritance, fifty-one percent (51%) or more of the outstanding voting securities of the Company (whether directly, indirectly, beneficially or of record).  In making any such determination, transfers made by a person to an affiliate of such person (as determined by the Board of Directors of the Company), whether by gift, devise or otherwise, shall not be taken into account.  For purposes of the Plan, ownership of voting securities shall take into account and shall include ownership as determined by applying the provisions of Rule 13d-3(d)(1)(i) as in effect on the date hereof pursuant to the Exchange Act.

Notwithstanding the provisions of subparagraph (iv) of this Section 8, the term “person,” as used in such subparagraph, shall not include any holder who was the beneficial owner of more than ten percent (10%) of the voting securities of the Company on the date the Plan was adopted by the Board of Directors.

9.Amendments to Plan.  The Committee is authorized to interpret the Plan and from time to time adopt such rules and regulations for carrying out the Plan as the Committee may deem advisable.  The Board of Directors of the Company may at any time amend, modify, suspend or terminate the Plan.  In no event, however, without the approval of stockholders, shall any action of the Board of Directors result in:

(a)Materially amending, modifying or altering the eligibility requirements provided in Section 4 hereof; or

(b)Materially increasing, except as provided in Section 5 hereof, the maximum number of shares available to be granted as Restricted Stock, except to conform the Plan and any agreements made hereunder to changes in the Code or governing law.

10.Investment Representation, Approvals and Listing.  The Committee may, if it deems appropriate, condition any grant of Restricted Stock made hereunder upon receipt of the following investment representation from the Grantee:

“I agree that any shares of the Common Stock of Uranium Resources, Inc., which I may

A-4

acquire by virtue of my acceptance of this Restricted Stock grant shall be acquired for investment purposes only and not with a view to distribution or resale, and may not be transferred, sold, assigned, pledged, hypothecated or otherwise disposed of by me unless (i) a registration statement or post-effective amendment to a registration statement under the Securities Act of 1933, as amended, with respect to said shares of Common Stock has become effective so as to permit the sale or other disposition of said shares by me; or (ii) there is presented to Uranium Resources, Inc., an opinion of counsel satisfactory to Uranium Resources, Inc., to the effect that the sale or other proposed disposition of said shares of Common Stock by me may lawfully be made otherwise than pursuant to an effective registration statement or post-effective amendment to a registration statement relating to the said shares under the Securities Act of 1933, as amended.”

The Company shall not be required to issue any certificate or certificates representing shares of Common Stock in connection with any grant of Restricted Stock made under the Plan prior to (i) the obtaining of any approval from any governmental agency which the Committee shall, in its sole discretion, determine to be necessary or advisable; (ii) the admission of such Stock to listing on any national securities exchange on which the Common Stock may be listed; (iii) the completion of any registration requirements or other qualifications imposed on the Common Stock by any state or federal law or ruling or regulations of any governmental body which the Committee shall, in its sole discretion, determine to be necessary or advisable or the determination by the Committee, in its sole discretion, that any registration or other qualification of the Common Stock is not necessary or advisable; and (iv) the obtaining of an investment representation from the Grantee in the form stated above or in such other form as the Committee, in its sole discretion, shall determine to be adequate.

11.General Provisions.  The form and substance of Restricted Stock Grant Agreements made hereunder need not be identical.  Nothing in the Plan or in any agreement (whether or not such agreement constitutes a Restricted Stock Grant Agreement) shall confer upon any employee any right to continue in the employ of the Company or any subsidiary corporation, to be entitled to any remuneration or benefits not set forth in the Plan or any related Restricted Stock Grant Agreement, or to interfere with or limit the right of the Company or any subsidiary corporation to terminate such employee’s employment at any time, with or without cause.

The Plan may be assumed by the successors and assigns of the Company.  The liability of the Company under the Plan is limited to the obligations set forth herein, and no term or provision of the Plan shall be construed to impose any liability on the Company in favor of any employee with respect to any loss, cost or expense which such employee may incur in connection with or arising out of any grant or agreement made in connection with the Plan.  All expenses arising from or associated with administering the Plan shall be borne by the Company.  The captions and section numbers appearing in the Plan are inserted only as a matter of convenience, and do not define, limit, construe or describe the scope or intent of the provisions of the Plan.

12.Termination of This Plan.   The Plan shall terminate on April 10, 2017.  Thereafter no Restricted Stock shall be granted hereunder.  Any and all shares of unvested Restricted Stock outstanding at the time of termination of the Plan shall continue in full force and effect in accordance with their restrictions and subject to the terms and conditions of this Plan and any related Restricted Stock Grant Agreements.

As adopted on April 10, 2007 by the Board of Directors and approved by the stockholders on               , 2007.

A-5

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Paul K. Willmott, certify that:

1.I have reviewed this report on Form 10-Q of Uranium Resources, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;

4.          The issuer’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have:

(a)  Designed  such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)  Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the issuer’s most recent fiscal quarter (the issuer’s first fiscal quarter of the annual report) that has materially affected or is reasonably likely to materially affect, the issuer’s internal control over financial reporting; and

5.          The issuer’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of issuer’s board of directors (or persons performing the equivalent functions):

(a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

(b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

Date: May 10, 2007
	/s/ Paul K. Willmott
	Title:  President and Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Thomas H. Ehrlich, certify that:

1.I have reviewed this report on Form 10-Q of Uranium Resources, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report.

4.The issuer’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have:

(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)  Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the issuer’s most recent fiscal quarter (the issuer’s first fiscal quarter of the annual report) that has materially affected or is reasonably likely to materially affect, the issuer’s internal control over financial reporting; and

5.The issuer’s other certifying officers and I have disclosed, based on our most recent evaluation, to the  issuer’s auditors and the audit committee of issuer’s board of directors (or persons performing the equivalent functions):

(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

Date: May 10, 2007
	/s/ Thomas H. Ehrlich
	Title:  Vice President - Finance and Chief Financial Officer

EX-32.1

Exhibit 32.1

URANIUM RESOURCES, INC.

650 S. Edmonds Lane, Suite 108, Lewisville, TX 75067

972.219.3330 Phone   972.219.3311 Fax

May 10, 2007

Securities and Exchange Commission

450 5th Street, N.W.

Washington, D.C. 20549

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Paul K. Willmott, President and Chief Executive Officer of Uranium Resources, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)  The Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2007 which this certification accompanies fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Paul K. Willmott

Paul K. Willmott

President and Chief Executive Officer

May 10, 2007

EX-32.2

Exhibit 32.2

URANIUM RESOURCES, INC.

650 S. Edmonds Lane, Suite 108, Lewisville, TX 75067

972.219.3330 Phone   972.219.3311 Fax

May 10, 2007

Securities and Exchange Commission

450 5th Street, N.W.

Washington, D.C. 20549

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Thomas H. Ehrlich, Vice President - Finance and Chief Financial Officer of Uranium Resources, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)  The Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2007 which this certification accompanies fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Thomas H. Ehrlich

Thomas H. Ehrlich

Vice President and Chief Financial Officer

May 10, 2007